Enanta Pharmaceuticals (ENTA) Q1 2023 Earnings

8MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.98
-1.74
-1.51
-1.27

Details

Expected EPS
-1.98
Actual EPS
-1.79
Surprise EPS
0.19
Surprise Percent
+9.6%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -1.79 per share for Q1 2023.

0 Comments

Share your thoughts